Does dipeptidyl peptidase-4 inhibition prevent the diabetogenic effects of glucocorticoids in men with the metabolic syndrome? A randomized controlled trial

Extra-pancreatic effects of incretin-based therapies: potential benefit for cardiovascular-risk management in type 2 diabetes

(2012) R. E. van Genugten et al.   DIABETES OBESITY & METABOLISM

Steroid-induced insulin resistance and impaired glucose tolerance are both associated with a progressive decline of incretin effect in first-degree relatives of patients with type 2 diabetes

(2012) D. H. Jensen et al.   DIABETOLOGIA

Mechanisms for the Antihyperglycemic Effect of Sitagliptin in Patients with Type 2 Diabetes

(2012) Elza Muscelli et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Islet-cell dysfunction induced by glucocorticoid treatment: potential role for altered sympathovagal balance?

(2012) Daniël H. van Raalte et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Screening for diabetes in patients with inflammatory rheumatological disease administered long-term prednisolone: a cross-sectional study

(2012) M. G. Burt et al.   RHEUMATOLOGY

Glucose tolerance, insulin sensitivity and  -cell function in patients with rheumatoid arthritis treated with or without low-to-medium dose glucocorticoids

(2011) J. N. Hoes et al.   ANNALS OF THE RHEUMATIC DISEASES

Prednisolone-induced beta cell dysfunction is associated with impaired endoplasmic reticulum homeostasis in INS-1E cells

(2011) Margot M.L. Linssen et al.   CELLULAR SIGNALLING

Twenty-four-hour profiles of plasma glucose, insulin, C-peptide and free fatty acid in subjects with varying degrees of glucose tolerance following short-term, medium-dose prednisone (20 mg/day) treatment: evidence for differing effects on insulin secreti

(2011) Kevin C. J. Yuen et al.   CLINICAL ENDOCRINOLOGY

Glucagon-Like Peptide-1 Receptor Agonist Treatment Prevents Glucocorticoid-Induced Glucose Intolerance and Islet-Cell Dysfunction in Humans

(2011) D. H. van Raalte et al.   DIABETES CARE

Low-dose glucocorticoid treatment affects multiple aspects of intermediary metabolism in healthy humans: a randomised controlled trial

(2011) D. H. van Raalte et al.   DIABETOLOGIA

Molecular physiology of glucagon-like peptide-1 insulin secretagogue action in pancreatic β cells

(2011) Colin A. Leech et al.   PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY

Acute and 2-week exposure to prednisolone impair different aspects of β-cell function in healthy men

(2010) Daniël H van Raalte et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Reduced Glucose Tolerance and Insulin Resistance Induced by Steroid Treatment, Relative Physical Inactivity, and High-Calorie Diet Impairs the Incretin Effect in Healthy Subjects

(2010) K. B. Hansen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Ectopic Fat Storage in the Pancreas, Liver, and Abdominal Fat Depots: Impact on β-Cell Function in Individuals with Impaired Glucose Metabolism

(2010) N. J. van der Zijl et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Genetic influences on the insulin response of the beta cell to different secretagogues

(2009) A. M. C. Simonis-Bik et al.   DIABETOLOGIA

Glucocorticoid-Induced Hyperglycemia

(2009) John Clore et al.   Endocrine Practice

Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options?

(2009) D. H. van Raalte et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Effects of exenatide versus sitagliptin on postprandial glucose, insulin and glucagon secretion, gastric emptying, and caloric intake: a randomized, cross-over study

(2008) Ralph A. DeFronzo et al.   CURRENT MEDICAL RESEARCH AND OPINION

Lack of association between glucocorticoid use and presence of the metabolic syndrome in patients with rheumatoid arthritis: a cross sectional study

(2008) Tracey E Toms et al.   ARTHRITIS RESEARCH & THERAPY